Insider · CIK 0001458494

Vaishnaw Akshay

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001458494

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	SRRKScholar Rock Holding CorpS Sale	Director, President of R&D	SSale	−12.2K sh	$49.57	−$607K	630,542
2026-02-09	SRRKScholar Rock Holding CorpA Award	Director, President of R&D	AAward	+47K sh	—	—	642,788
2026-01-13	SRRKScholar Rock Holding CorpS Sale	Director, President of R&D	SSale	−20.4K sh	$42.70	−$873K	595,767
2025-05-29	SRRKScholar Rock Holding CorpS Sale	Director, President of R&D	SSale	−5,130 sh	$29.63	−$152K	617,825
2025-05-29	SRRKScholar Rock Holding CorpS Sale	Director, President of R&D	SSale	−1,620 sh	$30.01	−$48.6K	616,205
2025-05-02	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, President of R&D	AAward	+110K sh	—	—	110,067
2025-04-27	SRRKScholar Rock Holding CorpA Award	Director, President of R&D	AAward	+100K sh	—	—	122,955
2025-04-27	SRRKScholar Rock Holding CorpA Award	Director, President of R&D	AAward	+500K sh	—	—	622,955
2024-06-27	SRRKScholar Rock Holding CorpA Award	Director, President of R&D	AAward	+13.5K sh	—	—	22,955
2024-06-27	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, President of R&D	AAward	+18K sh	—	—	18,000
2024-05-30	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−771 sh	$184.70	−$142K	26,060
2023-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−1,869 sh	$185.54	−$347K	24,191
2023-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−1,107 sh	$186.39	−$206K	23,084
2023-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−101 sh	$187.37	−$18.9K	22,983
2023-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−17 sh	$188.40	−$3,202.8	22,966
2023-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−192 sh	$189.31	−$36.3K	22,774
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	President	AAward	+5,082 sh	—	—	22,972
2023-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	President	AAward	+3,859 sh	—	—	26,831
2023-06-21	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, President of R&D	AAward	+36K sh	—	—	36,000
2023-06-01	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-04-27	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−197 sh	$193.18	−$38.1K	20,085
2023-04-27	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−910 sh	$193.93	−$176K	19,175
2023-04-27	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−1,013 sh	$194.94	−$197K	18,162
2023-04-27	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−104 sh	$195.65	−$20.3K	18,058
2023-04-27	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−168 sh	$197.08	−$33.1K	17,890
2023-04-26	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	President	AAward	+5,312 sh	—	—	20,282
2023-02-27	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	President	AAward	+5,790 sh	—	—	5,790
2023-02-27	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	President	AAward	+12K sh	—	—	11,986
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+30.9K sh	$63.00	+$1.95M	53,014
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−1,709 sh	$213.13	−$364K	51,305
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−2,307 sh	$214.28	−$494K	48,998
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−10.3K sh	$215.59	−$2.22M	38,719
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−19.4K sh	$216.38	−$4.21M	19,272
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−4,302 sh	$217.05	−$934K	14,970
2023-02-10	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−30.9K sh	—	—	0
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+1,124 sh	$88.95	+$100K	19,470
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+1,587 sh	$63.00	+$100K	21,057
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+2,368 sh	$42.22	+$100K	23,425
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	President	FTax Payment	−1,324 sh	$226.20	−$299K	22,101
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−2,368 sh	—	—	0
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−1,587 sh	—	—	30,913
2022-12-05	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−1,124 sh	—	—	28,876
2022-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	President	FTax Payment	−198 sh	$210.75	−$41.7K	18,346
2022-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	President	FTax Payment	−5,479 sh	$189.76	−$1.04M	18,919
2022-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	President	FTax Payment	−195 sh	$210.22	−$41K	18,724
2022-08-04	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	President	FTax Payment	−180 sh	$210.66	−$37.9K	18,544
2022-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	President	AAward	+5,083 sh	—	—	16,298
2022-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	President	AAward	+4,241 sh	—	—	20,539
2022-08-03	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	President	AAward	+3,859 sh	—	—	24,398

Recent filings

Accepted (ET)
Apr 204
Vaishnaw Akshay0001104659-26-045583
SEC(opens sec.gov)
Feb 114
Vaishnaw Akshay0001104659-26-013588
SEC(opens sec.gov)
Jan 154
Vaishnaw Akshay0001104659-26-004222
SEC(opens sec.gov)
May 304
Vaishnaw Akshay0001415889-25-015001
SEC(opens sec.gov)
May 64
Vaishnaw Akshay0001104659-25-045116
SEC(opens sec.gov)
Apr 294
Vaishnaw Akshay0001104659-25-041460
SEC(opens sec.gov)
Jul 14
Vaishnaw Akshay0001415889-24-018649
SEC(opens sec.gov)
Jun 34
Vaishnaw Akshay0001650664-24-000054
SEC(opens sec.gov)
Aug 74
Vaishnaw Akshay0001735276-23-000076
SEC(opens sec.gov)
Jun 224
Vaishnaw Akshay0001415889-23-010207
SEC(opens sec.gov)

Companies

Address

C/O HEMAB THERAPEUTICS HOLDINGS, INC. 101 MAIN STREET, SUITE 1220

CAMBRIDGE, MA, 02142